Risk factors of adverse drug reactions of first-line antiretroviral therapy in HIV patients at RSUD Dr. Moewardi

Authors

  • Ana Amalia Stikes Karya Putra Bangsa Tulungagung
  • Fita Rahmawati Faculty of Pharmacy, Universitas Gadjah Mada

DOI:

https://doi.org/10.12928/pharmaciana.v10i2.15658

Keywords:

risk factors for ADRs, HIV, antiretrovirals

Abstract

Acquired Immuno Deficiency Syndrome (AIDS) is an infection caused by the Human Immunodeficiency Virus (HIV). The antiretrovirals (ARVs) combination is the basis for the management of therapy in HIV/AIDS patients, but it often raises problems like adverse drug reactions (ADRs). This study was conducted to determine the risk factors for the occurrence of ADRs in the use of first-line ARVs. It employed a cross-sectional design with retrospective data collection in patients visiting the Voluntary Cell Counting (VCT) room of RSUD Dr. Moewardi in November-December 2018. The data collected were sociodemographic, behavioral, and clinical characteristics, laboratory test results, and ARV profiles. Findings show that the risk factors for ADRs in the use of first-line ARVs are CD4 of <200 and 0-24 months of taking ARVs.

References

Anshu Kumar, Gadgade, A., Shenoy, A. K., Chowta, M. N., & Ramapuram, J. T. (2015). Evaluation of adverse drug reactions in HIV positive patients in a tertiary care hospital. Perspectives in Clinical Research, 6, 34–38.

Anwar, Y., Nugroho, sucahyo adi, & Tantri, niken diaz. (2018). Karakteristik Sosiodemografi, Klinis, dan Pola Terapi Antiretroviral Pasien HIV/AIDS di RSPI Prof. Dr. Sulianti Saroso Periode Januari-Juni 2016. Pharmaceutical Journal of Indonesia, 15, 72–89.

Badan Pengawas Obat dan Makanan Republik Indonesia. (2012). Pedoman Monioring Efek Samping Obat (MESO) Bagi Tenaga Kesehatan. Pedoman Monitoring Efek Samping Obat (MESO) bagi Tenaga Kesehatan.

Butarbutar, Lubis, J. T., & Rahayu Hiswani. (2014). Karakteristik Penderita HIV/AIDS Di RSUD Dr. Djasamen Saragih Pematangsiantar tahun 2013-2014, 1–7.

Direktorat Jenderal Pencegahan dan Pengendalian Penyakit. (2017). Laporan Perkembangan HIV/AIDS 7 Penyakit Menular Seksual (PIMS) Triwulan I Tahun 2017 (pp. 1–402).

Eluwa, G. I., Badru, T., & Akpoigbe, K. J. (2012). Adverse drug reactions to antiretroviral therapy (ARVs): Incidence, type and risk factors in Nigeria. BMC Clinical Pharmacology, 12.

Hidayati, N. R., Abdillah, S., & Keban, S. A. (2016). Analisis Adverse Drug Reactions Obat Anti Retroviral Pada Pengobatan Pasien Hiv / Aids Di Rsud Gunung Jati Cirebon Tahun 2013. Pharmaciana, 6, 79–88.

Ibrahim, K., H, Y. K., Rahayuwati, L., Nurmalisa, B. E., & Fitri, S. U. R. (2017). Hubungan antara Fatigue , Jumlah CD4 , dan Kadar Hemoglobin pada Pasien yang Terinfeksi Human Immunodeficiency Virus ( HIV ). Jurnal Keperawatan Padjadjaran, 5, 271–280.

Kambu, Y., Waluyo, A., & Kuntarti. (2016). Umur Orang Dengan HIV/AIDS (ODHA) Berhubungan Dengan Tindakan Pencegahan Penularan HIV. Journal Keperawatan Indonesia, 19, 200–207.

Kementerian Kesehatan Republik Indonesia - Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan. (2011). Pedoman Nasional Tatalaksana Klinis Infeksi HIV dan Terapi Antiretroviral pada Orang Dewasa. Jakarta.

Kumari, R., Chandra, S., Gari, M., & Kumari, A. (2017). An assessment of adverse drug reaction patterns among HIV positive patients receiving antiretroviral therapy in a tertiary care hospital. International Journal of Pharmacological Research, 7, 88–93.

Lameshow, S., Hosmer, D. W., & Klar, J. (1997). Besaran Sampel Dalam Penelitian Kesehatan. Gadjah Mada University Press.

Lartey, M., Essel, A., Asante-Quarshie, A., Kenu, E., Ganu, V., & Neequaye, A. (2014). adverse drug reactions to antiretroviral therapy during the early art period at a tertiary hospital in Ghana. Pan African Medical Journal, 18, 1–6.

Li, H., Marley, G., Ma, W., Wei, C., Lackey, M., Ma, Q., … Tucker, J. D. (2017). The Role of ARV Associated Adverse Drug Reactions in Influencing Adherence Among HIV-Infected Individuals: A Systematic Review and Qualitative Meta-Synthesis. AIDS and Behavior, 21, 341–351.

Masenyetse, L. J., Manda, S. O. M., & Mwambi, H. G. (2015). An assessment of adverse drug reactions among HIV positive patients receiving antiretroviral treatment in South Africa. AIDS Research and Therapy, 12, 1–8.

Mendes, J. C., Bonolo, P. D. F., Ceccato, M. D. G. B., Costa, J. D. O., Reis, A. M. M., Dos Santos, H., & Silveira, M. R. (2018). Adverse reactions associated with first-line regimens in patient initiating antiretroviral therapy. European Journal of Clinical Pharmacology, 1–12.

Modayil, retty rajan, & Harugeri, A. (2011). Adverse drug reactions to antiretroviral therapy ( ART ): an experience of spontaneous reporting and intensive monitoring from ART centre in India. Pharmacoepidemiology and Drug Safety, 247–255.

Namme Luma, H., Doualla, M.-S., Choukem, S.-P., Temfack, E., Ashuntantang, G., Achu Joko, H., … Koulla-Shiro, S. (2012). Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study. The Pan African Medical Journal, 12, 87.

Pádua, C. A. M. De. (2006). High incidence of adverse reactions to initial antiretroviral therapy in Brazil. Brazilian Journal of Medical and Biological Research, 495–505.

Prosperi, M. C. F., Fabbiani, M., Fanti, I., Zaccarelli, M., Colafigli, M., Mondi, A., … Giambenedetto, S. Di. (2012). Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients : a retrospective cohort study. BMC Infectious Disease.

Tadesse, W. T., Mekonnen, A. B., & Tesfaye, W. H. (2014). Self-reported adverse drug reactions and their influence on highly active antiretroviral therapy in HIV infected patients : a cross sectional study, 15, 1–9.

Tatiparthi, R., & Mamo, Y. (2015). Prevalence of ADRs and Associated Factors of Antiretroviral Treatment on HIV Positive Adults at Jush. Indian Journal of Pharmacy Practice, 7, 8–15.

Yuliandra, Y., Nosa, ulfa syafli, Raveinal, & Almasdy, D. (2017). Terapi Antiretroviral pada Pasien HIV / AIDS di RSUP . Dr . M . Djamil Padang: Kajian Sosiodemografi dan Evaluasi Obat. Jurnal Sains Farmasi & Klinis, 4, 1–8.

Downloads

Published

2020-07-29

Issue

Vol. 10 No. 2 (2020): Pharmaciana

Section

Clinical and Community Pharmacy

License

Authors who publish with Pharmaciana agree to the following terms:

  1. Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.